Antonella d'Arminio Monforte at Università degli Studi di Milano - Research Interests, Publications & Academic Profile

Antonella d'Arminio Monforte

Full Professor

Università degli Studi di Torino

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

80%

Immunology

30%

Hiv

100%

Antiretroviral Therapy

40%

Antiviral Therapy

40%

Covid-19

30%

Hepatitis C

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy

Article Link

Year:

2024

Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects

Article Link

Year:

2024

Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort

Article Link

Year:

2024

Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis

Article Link

Year:

2023

Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort

Article Link

Year:

2023

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV

Article Link

Year:

2023

HIV-Indicator Condition Guided Testing in a Hospital Setting

Article Link

Year:

2023

HIV‐NAAT use for early detection of HIV infection among high‐risk men who have sex with men in Italy

Article Link

Year:

2023

SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio

Article Link

Year:

2023

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

Article Link

Year:

2023

Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with <scp>HIV</scp>: Real‐world insights from <scp>BICSTaR</scp> cohorts

Article Link

Year:

2023

Management of Chronic Hepatitis B in HIV-Coinfected Patients

Article Link

Year:

2022

Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19

Article Link

Year:

2022

Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease

Article Link

Year:

2022

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

Article Link

Year:

2022

Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

Article Link

Year:

2021

Collaborators17

Alexy Inciarte

Associated profesor

University of Barcelona

SPAIN

Christoph Stephan

University Hospital Frankfurt

GERMANY

João Marques-Gomes

Universidade de Aveiro

PORTUGAL

Anna Maria AZZINI

Aggregate Professor

University of Verona

ITALY

Federico D'AMICO

University of Milan

ITALY

Teresa A. Santantonio

University of Foggia

ITALY

Simone Lanini

Associate Professor

University of Udine

ITALY

John Thornhill

Imperial College London

UNITED KINGDOM

Camilla Tincati

University of Milan

ITALY

GIULIA CARLA MARCHETTI

University of Milan

ITALY

Sergio Lo Caputo

Associate Professor

Università degli Studi di Foggia

ITALY

loredana sarmati

Associate Professor of Infectious Diseases

Università degli Studi di Roma La Sapienza

ITALY

Camilla Muccini

Vita-Salute San Raffaele University

ITALY

Jennifer Hoy

MONASH UNIVERSITY

AUSTRALIA

ANDREA COSTANTINI

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

ITALY

Josep M. Llibre

SPAIN

Elda Righi

Associate Professor

University of Verona

ITALY

How do I reach out?

Meet Kite AI